The generic name of Ezekiel is Recombinant Human Type II Tumor Necrosis Factor Receptor-Antibody Fusion Protein for Injection and is not recommended for lifetime use in patients with ankylosing spondylitis. Recombinant Human Type II Tumor Necrosis Factor Receptor-Antibody Fusion Protein for Injection is mainly used to treat moderately and severely active arthritis, ankylosing spondylitis, and moderate-to-severe plaque psoriasis in adults over the age of 18. After administration, some patients may also experience adverse reactions such as pruritus, headache, dizziness, rash, cough, rhinitis, and muscle aches. It is contraindicated in patients with sepsis, active tuberculosis, and patients with allergic reactions to the components of recombinant human type II tumor necrosis factor receptor-antibody fusion protein for injection. Note that in the event of serious infections such as secondary infection of diabetes mellitus and Mycobacterium tuberculosis infection during use, the product should be immediately discontinued and prompt medical attention should be sought. For people who do not consider pregnancy for the time being, as well as conventional ways of treatment of ankylosing spondylitis treatment is not obvious, the condition of recurrent episodes can not be controlled, you can choose to use recombinant human type II tumor necrosis factor receptor-antibody fusion protein, the general recommendation of the treatment for 3 to 6 months, but also according to the condition of the extension of the use of time. However, constant use is generally not recommended. It is recommended that patients with ankylosing spondylitis consult the rheumatology and immunology department in a timely manner and under the guidance of the doctor for standardized treatment.